课题基金 / 基金详情

Innate Immunity and Hepatitis C Virus Infection.

Innate Immunity and Hepatitis C Virus Infection.
先天免疫和丙型肝炎病毒感染。
批准号:
178483
负责人:
Lin Rongtuan
金额:
$63.49万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-03-01 至 2014-03-01

项目摘要

项目成果

Lin Rongtuan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
With more than 170 million people infected worldwide, the hepatitis C virus (HCV) is an important cause of human chronic liver diseases and a major public health problem. Clinically, of those individuals exposed to HCV, 80% become continuously infected, a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the role of TRAF7 in regulating antiviral immune response
Investigating the role of TRAF7 in regulating antiviral immune response
Investigate the potential of Nrf2 modulators as antiviral and anticancer therapeutics
Manipulating the immune response to inhibit Ebola virus infection
海外基金